Literature DB >> 27238709

Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta.

Ji Hyae Lim1, Shin Young Kim1, Jung Yeol Han2, Moon Young Kim2, So Yeon Park3, Hyun Mee Ryu4.   

Abstract

INTRODUCTION: Trisomy 21 (T21) is the most common aneuploidy affecting humans and is caused by an extra copy of all or part of chromosome 21 (chr21). DNA methylation is an epigenetic event that plays an important role in human diseases via regulation of gene expression. However, the integrative association between DNA methylation and gene expression in T21 fetal placenta has yet to be determined.
METHODS: We profiled expression of 207 genes on chr21 and their DNA methylation patterns in placenta samples from normal and DS fetuses using microarray analysis and predicted the functions of differentially expressed genes using bioinformatics tools.
RESULTS: We found 47 genes with significantly increased expression in the T21 placenta compared to the normal placenta. Hypomethylation of the 47 genes was observed in the T21 placenta. Most of hypomethylated DNA positions were intragenic regions, i.e. regions inside a gene. Moreover, gene expression and hypomethylated DNA position showed significantly positive associations. By analyzing the properties of the gene-disease network, we found that increased genes in the T21 placenta were significantly associated with T21 and T21 complications such as mental retardation, neurobehavioral manifestations, and congenital abnormalities. DISCUSSION: To our knowledge, this is the first study to comprehensively survey the association between gene expression and DNA methylation in chr21 of the T21 fetal placenta. Our findings provide a broad overview of the relationships between gene expression and DNA methylation in the placentas of fetuses with T21 and could contribute to future research efforts concerning genes involvement in disease pathogenesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chromosome 21; DNA methylation; Gene expression; Placenta; Trisomy 21

Mesh:

Year:  2016        PMID: 27238709     DOI: 10.1016/j.placenta.2016.03.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  Expression patterns of the chromosome 21 MicroRNA cluster (miR-99a, miR-125b and let-7c) in chorioamniotic membranes.

Authors:  Bhavi P Modi; Sonya Washington; Scott W Walsh; Colleen Jackson-Cook; Kellie J Archer; Jerome F Strauss
Journal:  Placenta       Date:  2016-11-09       Impact factor: 3.481

Review 2.  Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.

Authors:  Y Eugene Yu; Zhuo Xing; Catherine Do; Annie Pao; Eun Joon Lee; Sharon Krinsky-McHale; Wayne Silverman; Nicole Schupf; Benjamin Tycko
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

Review 3.  Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models.

Authors:  Catherine Do; Zhuo Xing; Y Eugene Yu; Benjamin Tycko
Journal:  Epigenomics       Date:  2016-12-02       Impact factor: 4.778

4.  Global impacts of chromosomal imbalance on gene expression in Arabidopsis and other taxa.

Authors:  Jie Hou; Xiaowen Shi; Chen Chen; Md Soliman Islam; Adam F Johnson; Tatsuo Kanno; Bruno Huettel; Ming-Ren Yen; Fei-Man Hsu; Tieming Ji; Pao-Yang Chen; Marjori Matzke; Antonius J M Matzke; Jianlin Cheng; James A Birchler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-14       Impact factor: 11.205

5.  A novel CpG-based signature for survival prediction of lung adenocarcinoma patients.

Authors:  Rongjiong Zheng; Haiqi Xu; Wenjie Mao; Zhennan Du; Mingming Wang; Meiling Hu; Xiaolong Gu
Journal:  Exp Ther Med       Date:  2019-11-15       Impact factor: 2.447

6.  Genome-wide gene expression analysis in the placenta from fetus with trisomy 21.

Authors:  Ji Hyae Lim; You Jung Han; Hyun Jin Kim; Dong Wook Kwak; So Yeon Park; Sun-Hee Chun; Hyun Mee Ryu
Journal:  BMC Genomics       Date:  2017-09-12       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.